secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001641172-25-020896
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio announces $3.9M warrant exercise; issues new warrants for up to 8.6M shares
--------------------------------------------------------------------------------

- Existing warrant holders exercised 4,318,905 shares at reduced price $0.9047 (from $1.40); gross proceeds ~$3.9M.
- Holders receive new unregistered warrants to purchase up to 8,637,810 shares at $0.9047, 5-year term, exercisable after stockholder approval.
- Company to seek stockholder approval within 60 days; new warrants include cashless exercise after 6 months if registration not effective.
- Pays placement agent Ladenburg Thalmann 8% cash fee plus 6% warrants; net proceeds for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000164117225020896/0001641172-25-020896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000164117225020896/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer